retatrutide clinical trial results side effects More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase better sleep Retatrutide Achieves Up to Size:150 GM

retatrutide clinical trial results side effects More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase better sleep Retatrutide Achieves Up to Size:150 GM

Retatrutide Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial | AJMC

1.3% on placebo Roughly a tenfold excess over placebo in TRIUMPH-2, fivefold in TRIUMPH-3, and dose-dependent in the diabetes trial

better sleep

Size:150 GM

This is a niche of the industry where Novo Nordisk is even beating Eli Lilly